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Abstract – Genetic mutations with major eﬀects on ovulation rate in sheep were recently
identiﬁed in two genes of the transforming growth factor (TGFβ) superfamily and a TGFβ
receptor, namely bone morphogenetic protein 15 (BMP15), otherwise known as the growth
diﬀerentiation factor 9b (GDF9b), GDF9 and activin-like kinase 6 (ALK6) otherwise known
as the BMP receptor type IB (BMPRIB). Animals homozygous for the BMP15 or GDF9
mutations are anovulatory whereas animals heterozygous for BMP15 or GDF9 or heterozy-
gous or homozygous for ALK6 have higher than normal ovulation rates. Immunisation of ewes
against BMP15 or GDF9 shows that both are essential for normal follicular development and
control of ovulation rate. Common features of fertile animals with the BMP15, ALK6 (and
possibly GDF9) mutations are changes in oocyte development during early preantral follicular
growth, earlier maturation of granulosa cells and ovulation of mature follicles at smaller diam-
eters. In summary, these ﬁndings have led to a new paradigm in reproductive biology, namely
that the oocyte plays a key role in regulating the ovulation rate.
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1. INTRODUCTION
Sheep (Ovis aries) are a highly diverse species with more than 900 diﬀerent
breeds that vary substantially in their physiological characteristics including
ovulation rate and fecundity [30]. In some instances, the diﬀerences in
ovulation rate have been attributed to the action of a single or a closely-
linked group of genes [4]. Indeed mutations with major eﬀects on ovulation
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rate have been identiﬁed in two genes of the transforming growth factor beta
(TGFβ) superfamily and a TGFβ receptor, namely bone morphogenetic pro-
tein (BMP15), growth diﬀerentiation factor 9b (GDF9) and BMP receptor-IB
(ALK6) [10, 11, 23, 28, 33]. Further mutations in some of these genes or in
diﬀerent genes are likely to be present in other proliﬁc breeds.
The aforementioned gene discoveries have led to a new paradigm in
reproductive biology, namely that the oocyte plays a key role in regulating the
ovulation rate [10–12]. Thus, sheep are proving to be remarkably informative
in oﬀering new insights into why some mammals have a predisposition to
produce two or three oﬀspring rather than one [18]. The purpose of this review
was to summarise some of the physiological eﬀects of the BMP15, GDF9 and
ALK6 mutations aﬀecting ovulation rate in sheep.
2. THE BMP15 AND GDF9 MUTATIONS
Five separate point mutations in the BMP15 gene and one point muta-
t i o ni nt h eGDF9 gene have been identiﬁed as aﬀecting the ovulation rate
[2,10,11]. Animals homozygous for each of these mutations are anovula-
tory and thus sterile whereas heterozygous animals have mean ovulation rates
between 0.8 and 2.4 above that of the respective non-carrier ﬂocks [5, 11].
Two of the ﬁve BMP15 mutations have premature stop codons, one of these
(FecXG in Belclare and Cambridge sheep) is at amino acid position −29 in
the proregion of exon 2 before the mature region thus no mature protein is
produced and the other is the Hanna mutation (FecXH)a ta m i n oa c i d2 3
of the mature protein rendering it inactive. Another two mutations are non-
conservative amino acid substitutions within the mature protein at amino acid
positions 31 (Inverdale; FecXI) and 99 (Belclare; FecXB). The other identi-
ﬁed mutation has been reported in Lacaune ewes and is reported elsewhere
in this journal [2]. This mutation was found as a co-dominant mutation in
an animal with an autosomal gene aﬀecting ovulation rate. For all mutations,
the ovarian phenotypes are indistinguishable in homozygous carriers, in that
few, if any, follicles develop beyond the primary (i.e. type 2) stage of de-
velopment (Fig. 1). The GDF9 mutation (Belclare; FecGH) corresponds to a
non-conservative amino acid substitution at position 77 of the mature protein
region. The ovarian phenotype in animals homozygous for this mutation is dif-
ferent than that for the BMP15 mutations in that ovarian follicles continue to
develop to the antral (i.e. type 5) stages although most, if not all, are abnormal
with respect to oocyte morphology and the arrangement and appearance of the
granulosa and cumulus cell-types (Fig. 1).Physiological eﬀects on ovulation rate in sheep S27
Figure 1. Photomicrographs (a–d) showing normal type 4 (preantral) follicles in a
wild-type sheep (a) and abnormal ovarian follicles with similar diameter oocytes
(–80 µm) in an Inverdale ewe with a homozygous non-conservative aspartic acid
substitution for valine at amino acid 31 in BMP15 (b); in a Belclare ewe homozygous
for a stop codon at amino residue −29 (i.e. in the proregion of BMP15) (c) and in
a Belclare ewe with a homozygous isoleucine substitution for serine at amino acid
residue 77 in GDF9 (d). The photomicrographs (e) and (f) show immunostaining
for GDF9 and BMP15 in oocytes of type 1 (i.e. primordial) follicles and a type
2 (primary) follicle, respectively, whereas (g) and (h) show the corresponding
photomicrographs where the signal has been blocked with an ovine GDF9 peptide
or an E. coli derived ovine BMP15 mature protein respectively. The follicles shown
in photomicrographs (e–h) are from normal follicles in wild-type sheep. Scale bars
a–d = 70 µm; e–h = 25 µm.S28 K.P. McNatty et al.
The primary cause of infertility in ewes homozygous for the BMP15 or
GDF9 mutations is the apparent lack of bioactive BMP15 or GDF9. These
ﬁndings are in contrast to those reported for mice [7, 34]. GDF9 null mice
have been found to be sterile and follicular growth is blocked at the primary
stage, whereas inBMP15null mice, no obvious eﬀects onfollicular growth and
embryo development have been noted, although some defects in fertilisation
have been observed. In the heterozygous mice, no diﬀerences in ovulation rate
have been reported. To explain this paradox, Liao et al. [15] suggest that this
might be due to altered intracellular processing and secretion of BMP15 and
GDF9 because of the nature of the mutations in sheep and of the way in which
the mouse BMP15 gene is mutated by deleting the entire second exon. These
authors produced a recombinant human BMP15 with an amino acid substitu-
tion at position 31 which mimics the mutation in Inverdale sheep. They found
that a mutant dimerised form of BMP15 can be secreted from a cell line that
does not contain a GDF9 expression system. However, when the mutant form
ofBMP15isco-expressed with GDF9,the proteolytic processing and secretion
of BMP15 is inhibited and the secretion of GDF9 is impaired. It was proposed
that the mutations in the BMP15 gene in sheep may actually aﬀect the level
of GDF9 secretion and that abnormal concentrations of GDF9 are the cause of
the Inverdale phenotype. However, whensheep areimmunised against peptides
speciﬁc for BMP15 or GDF9, the evidence is that secreted forms of BMP15 as
well as GDF9 are essential for both normal follicular development and ovula-
tion rate [12,18].
2.1. The BMP15 and GDF9 immunisation experiments
The purpose of the immunisation experiments in sheep was to test whether
extracellular concentrations of GDF9 or BMP15 are important for the regula-
tion of follicular development and ovulation rate. To test this, the ewes were
immunised at monthly intervals for 7months withkeyhole limpethaemacyanin
(KLH) or KLH conjugated with an E. coli derived mature BMP15 protein
or with a 15mer GDF9 or BMP15 peptide respectively in Freunds adjuvant.
The major eﬀects on ovarian phenotype are a signiﬁcant reduction in ovar-
ian volume, no normal follicular development beyond the type 2 stage, few,
if any type 5 (i.e. antral) follicles and signiﬁcantly larger oocytes in the type
2-4 follicles in both the BMP15 and GDF9 groups [12]. This phenotype is
similar to that observed in sheep with the BMP15 and GDF9 mutations. Pas-
sive immunisation of ewes with BMP15 or GDF9 speciﬁc antibodies during
the follicular phase of the oestrous cycle showed that both factors are alsoPhysiological eﬀects on ovulation rate in sheep S29
essential during the preovulatory follicular maturation. In follow-up studies,
where ewes were given a primary and booster injection of KLH or bovine
serum albumin (BSA) conjugated to the BMP15 or GDF9 peptide, in a water-
based adjuvant, signiﬁcant increases in mean ovulation rates of around 0.4
to 1.2 were achieved relative to the KLH or BSA immunised controls [13]
(McNatty, Juengel, unpublished data). These ﬁndings suggest that a partial
neutralisation of BMP15 or GDF9 in biological ﬂuid leads to an ovulation re-
sponse similar to those observed in animals with the heterozygous mutations
of either BMP15 or GDF9 [10,11]. While these studies show that both GDF9
and BMP15 are essential for follicular growth and ovulation rate, they do not
rule out the possibility that some of their eﬀects are due to the presence of
BMP15/GDF9 heterodimers.
2.2. Intraovarian sites of BMP15 and GDF9 gene expression
and possible mechanisms of action
Within the sheep ovary, BMP15 and GDF9 are expressed exclusively by the
oocyte (Fig. 2). Both GDF9 mRNA and protein are present in normal sheep
oocytes in non-growing type 1 follicles (i.e. primordial follicles) as well as
in growing follicles [3, 12] (Fig. 1). In contrast, BMP15 mRNA and protein
are both present from the type 2 (i.e. primary) stage (Fig. 2). With respect to
receptors for the TGFβ/BMP ligands, BMPR-II, activin receptor-like kinase 6
(ALK6), ALK3,a n dALK5 mRNA are present in oocytes at all stages of follic-
ular growth [1,29,33] (Fig. 2; Juengel, unpublished data). In granulosa cells,
BMPR-II and ALK3are present at all stages including type 1 follicles, whereas
ALK6 is present from the type 2 stage and ALK5 from the type 4 stage of
growth. In theca interna cells, BMPR-II, ALK3, ALK5but not ALK6are present
from the type 4 stage of growth [1,32] (Fig. 2). However, a low level of ALK6
protein has been detected in theca by immunohistochemistry suggesting that
this receptor might be present [29]. Inrats, BMP15binds to ALK6with very lit-
tle aﬃnity for ALK3 and BMPR-II inhibits BMP15 induced cell functions [22]
suggesting that cells expressing both ALK6 and BMPR-II are probable targets
for the BMP15 ligand. If this holds true for sheep, then it is likely that gran-
ulosa cells and the oocyte are aﬀected by oocyte-derived BMP15 from the
type 2 stage of growth [33]. In rat granulosa cells, GDF9 is known to bind
to BMPR-II [32] and to stimulate inhibin A and B production via the Smad2
pathway [26] inferring that the type 1 receptor might be an activin or TGFβ
receptor rather than ALK3 or ALK6 [24]. Indeed a recent report shows that
ALK5 (TGFβRI) is the type 1 receptor for GDF9 [19]. This ﬁnding suggests
that GDF9could have autocrine eﬀects on the oocyte from the type 1 stage and
paracrine eﬀects on both the granulosa and theca cells from the type 4 (rangeS30 K.P. McNatty et al.
Figure 2. Onset of expression of GDF9, BMP15, BMP6 and receptors of the TGFβ
superfamily with respect to the stage of ovarian follicular development and respon-
siveness to pituitary gonadotrophins. The superscripts a, b and c refer to the oocyte,
granulosa cells and theca interna respectively. GDF9,g r o w t hd i ﬀerentiation factor 9,
BMP15, bone morphogenetic protein 15, BMP6, bone morphogenetic protein 6,
TGFβ,transforminggrowthfactorbeta,BMPRII,BMPreceptortypeII,ALK5,activin-
like kinase5 (otherwiseknownas TGFβRI or TGF beta receptortype 1), ALK3 (other-
wiseknownas BMPRIA),ALK6(otherwiseknownasBMPRIB),AMH,anti-Mullerian
hormone. ALK6? infers that some uncertainty remains as to whether this gene is ex-
pressed in theca cells (see text). Modiﬁed from Montgomery et al. [20].Physiological eﬀects on ovulation rate in sheep S31
preantral) stage of growth. It is worth noting that GDF9mRNA and protein are
present before follicular formation in sheep as well as in non-growing type 1
follicles in several species including sheep, cows and possum [3,8,12]. Thus,
either the form of the protein is biologically inactive, the appropriate receptors
are not present on the adjacent granulosa cells in type 1 follicles or that GDF9
is a relatively inactive growth factor when other companion factors are absent.
The roles of GDF9 and BMP15 as assessed from in vitro studies appear
complex with some possible species diﬀerences. In rodents, both BMP15 and
GDF9 stimulate proliferation of cultured granulosa cells from antral follicles,
whereas in sheep only recombinant ovine BMP15 has been shown to induce
modest proliferation [25,31] (McNatty, unpublished data). An explanation for
the higher ovulation rate observed in heterozygous Inverdale or Hanna ewes
has been oﬀered by Shimasaki and his colleagues [25] based on their in vitro
ﬁndings that BMP15 may reduce the sensitivity of granulosa cells to FSH
by inhibiting expression of the FSH receptor. Thus, in animals such as the
heterozygous Inverdale or Hanna with a lower than normal concentration of
BMP15, a higher FSH-induced granulosa cell responsiveness would result.
In granulosa cells from heterozygous Inverdale ewes, a higher FSH-induced
cAMP responsiveness has been observed relative to wild-type animals in the
absence of any diﬀerences in the plasma concentrations of FSH, LH or ovarian
steroids [27]. Since GDF9 has also been shown in rats to inhibit FSH-induced
cAMP synthesis [31], the overall eﬀect of the GDF9 mutation in sheep may be
to enhance the sensitivity of the ovarian follicle to FSH and thereby increase
the ovulation rate in a manner similar to that noted for BMP15.
2.3. The ALK6 (BMPR-IB) mutation
The ALK6 mutation was ﬁrst identiﬁed in Booroola ewes (FecB) as a point
mutation at nucleotide position 830 leading to an arginine replacing a glu-
tamine amino acid (i.e. Q249R) in a highly conserved region of the intra cellu-
lar kinase domain [23,28,33]. The dominant phenotype is precocious ovarian
follicular development [20] and exceptional proliﬁcacy [4]. Some signiﬁcant
secondary eﬀects have been observed in Booroola sheep, most likely because
ALK6 mRNA is present in a wide range of tissues as well as the ovaries, in-
cluding the brain, pituitary, kidneys, skeletal muscle, uterus and prostate and
testes [20, 33]. ALK6 mRNA is also likely to be expressed in several tissues
during fetal development such as the heart and mesonephros [17]. The evi-
dence for eﬀects of the Q249R ALK6 mutation in various tissues during fetal
development as well as on pituitary function and ovarian follicular formationS32 K.P. McNatty et al.
have been summarised elsewhere [20]. As reported by Davis [4], the Booroola
(Q249R ALK-6) mutation has now been identiﬁed in a number of diﬀerent
sheep breeds throughout the world.
The ALK6 knockout mouse does not display the same phenotype as the
Booroola ewe [36]. ALK6 knockout mice appear to have normal ovarian
follicular development and ovulation rates although there is a reduction in
fertility perhaps caused by the failure of normal cumulus expansion. Unlike
Booroola sheep, ALK6 null mice exhibit defects in chondrogenesis leading to
defects in skeletal development [35]. In two unrelated human families, point
mutations have been identiﬁed in the ALK6 gene [14]. In one family, the
mutation resulted in a lysine residue substituting for an isoleucine (I200K)
in a region of ALK6 involved in phosphorylation of the receptor. In the other
family, a tryptophan is substituted for an arginine (R486W) in a highly con-
served region of the C-terminal of the ALK6 kinase domain. These mutations
cause malformations in limb development but there are no reports of eﬀects on
fertility. Experiments to block the actions of putative ligands interacting with
the ALK6 receptor in sheep or mutating the ALK6 receptor in mice to generate
the Booroola mutant have not been reported. Thus, comparisons of the ALK6
mutation in sheep with the ALK6 knockout mice to explore mechanistic inter-
pretations of species diﬀerences in ovulation rate are premature.
2.4. Intraovarian eﬀects of ALK6 expression and possible
mechanisms of action
ALK6 together with BMPR-II mRNA have been identiﬁed in ovine oocytes
of type 1 follicles and expression levels for both remain high throughout the
follicular types 1-4 and early type 5 stages of growth [37] (Fig. 2). There-
after, the levels of ALK6 but not BMPR-II mRNA in oocytes decline in large
antral follicles [33]. Both ALK6 and BMPR-II mRNA are also present in gran-
ulosa cells from the type 2 stage of growth but little or no ALK6 is detectable
in theca interna cells (Fig. 2). It seems likely that there is a functional in-
teraction between BMP15 and ALK6 since the eﬀect on the ovulation rate is
multiplicative in Booroola Inverdale crossed sheep that are heterozygous for
the ALK6 and BMP15 mutations [6]. Moreover, it has been shown that the
BMP but not the TGFβ1 or activin A signalling pathway is altered in granulosa
cells from carriers of the Q249R ALK6 mutation [9,21]. Given that BMP6 and
BMP15 were expressed in ovine oocytes from the type 1 and 2 stages respec-
tively (Fig. 2; Juengel, unpublished data), it is reasonable to expect that one orPhysiological eﬀects on ovulation rate in sheep S33
Table I. Relationships between the granulosa cell numbers and follicular diameter
with respect to the Booroola genotype before, at and after an inﬂection point†.V a l u e s
are means ± s:e.m.
Genotype Follicular types 2-5 Ln Inﬂection point, Initial slope plus
slope pre-inﬂection µm( d) change in slope
(b) post-inﬂection
(b+g)†
++ 2.68±0.03 7.11±0.04 1.57±0.08
BB 2.87±0.05∗∗ 6.46±0.06∗∗ 2.05±0.08∗∗
†For each of the genotypes (BB = homozygous carriers of the Booroola gene; ++
homozygous non-carriers of the Booroola gene) the model ﬁtted was: Ln (granulosa
cell number) = a + b Ln (follicular diameter) + g [(Ln follicular diameter -d) × (Ln
follicular diameter > d)], where a = intercept, b = initial slope of Ln (granulosa cell
number) against Ln (follicular diameter), d = the inﬂection point along the Ln (follic-
ular diameter) axis and g is the change in slope from the initial slope to the ﬁnal slope
after the inﬂection point (unpublished data). **For each column, P<0.01.
both of these intrafollicular ligands would interact with the BMPR-II/mutant
ALK6 complex [10,11] to aﬀect some change in oocytes or granulosa cells in
early growing follicles and this appears to be the case. In animals that are ho-
mozygous carriers and non-carriers for the Booroola mutation, oocytes reach
their mature diameter of ∼130 µm at the types 4 and 5 stages of development
respectively [33]. This divergence between the genotypes in diameters of the
oocytes is already evident at the type 3 follicular stage. Changes in granu-
losa cell numbers with respect to follicular diameters (e.g. 75 to ≥3000µm)
have also been examined after ﬁtting a broken stick regression model (i.e.
2 straight lines with an inﬂection point) for each genotype (see Tab. I). The
results from analyses of the granulosa cell populations from the type 2 to type
5 stages of development show that the Booroola mutation inﬂuences granulosa
cell development both before as well as after antrum formation [16] (Tab. I).
In preantral follicles, the granulosa cells accumulate in greater numbers with
respect to follicular diameter in BB compared to ++ ewes until follicles reach
a 639 µm diameter. Thereafter in ++ ewes, the granulosa cells continue to
accumulate as beforehand until the follicles reach a 1224 µm diameter. Once
BB and ++ follicles reach the aforementioned respective diameters, the ac-
cumulation of granulosa cells with respect to follicular diameter changes but
it continues to remain higher in the BB genotype (Tab. I). However follicles
in BB ewes reached an ovulatory size at −3000µm diameter and in ++ ewesS34 K.P. McNatty et al.
between 5000 and 6000µm diameter with the mean numbers of granulosa cells
per preovulatory follicle being 1.9 million and ∼5 million, respectively. These
diﬀerences in oocyte and granulosa cell development in sheep with the Q249R
ALK6 mutation are associated with a signiﬁcantly higher FSH-induced cAMP
responsiveness and earlier onset of follicular steroidogenesis including earlier
onset of aromatase activity in granulosa cells, together with an earlier onset of
LH responsiveness in the granulosa cells (for a review, see [20]). All of these
events in the ALK6 mutated ewes lead to maturation and ovulation of multi-
ple ovarian follicles at smaller follicular diameters without any changes in the
ovarian secretion rates of steroid or inhibin during either the follicular or luteal
phases of the oestrous cycle [20]. These results when taken together with those
from Fabre et al. (2003) [9] suggest that some intraovarian factors have anti-
diﬀerentiative roles (e.g. anti-luteinising eﬀects) on ovine granulosa cells and
that one important consequence of the mutated ALK6 receptor is a decreased
ability of some BMP to inhibit diﬀerentiation. It remains to be determined
how speciﬁc BMP act on the BMPR-II complexes and how the downstream
signalling pathways of the mutated ALK6 receptor inﬂuences cell function in
Booroola sheep.
3. CONCLUSION
A common feature of the BMP15 and ALK6 mutations is that changes in
oocyte are evident during early preantral (i.e. type 3) development followed
by precocious follicular maturation with each preovulatory follicle containing
a reduced population of granulosa cells. Although not proven, the same
characteristics are likely to be true for sheep with the GDF9 mutation.
The immunisation studies show that both GDF9 and BMP15 are essential for
follicular development in sheep but it remains to be determined whether GDF9
and BMP15 act as heterodimers and whether these growth factors either sep-
arately or together exert their eﬀects through the ALK6 receptor. In summary,
these data suggest new possibilities for developing novel therapeutic reagents
for regulating fertility in mammals.
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